Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05641142
NA

Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia

Sponsor: University Hospital, Clermont-Ferrand

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to evaluate in real life, in patients with Hereditary Hemorrhagic Telangiectasia (HHT), the tolerance of the strategy of use of anticoagulant and/or antiplatelet, by comparing a new exposure period (first trimester of treatment) to a period of reference non-exposure (last trimester before start of treatment).

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2023-04-07

Completion Date

2029-04

Last Updated

2025-04-09

Healthy Volunteers

No

Interventions

OTHER

monitoring the use of anticoagulant and/or antiplatelet therapy in patients with osler rendering disease

Monitoring: * hemoglobin and ferritin levels * transfusion or intravenous iron * hospitalization for bleeding or thrombose * digestive bleeding and/or another haemorrhagic accident * severity of epistaxis * quality of life

Locations (18)

CHU d'Angers

Angers, France

CHU de Bordeaux

Bordeaux, France

Hôpital Ambroise Paré

Boulogne-Billancourt, France

CHU de Caen Normandie

Caen, France

CHU clermont-ferrand

Clermont-Ferrand, France

CHU de Dijon

Dijon, France

CHRU de Lille

Lille, France

Hospices Civiles de Lyon

Lyon, France

Assistance Publique - Hôpitaux de Marseille

Marseille, France

CHU de Montpellier

Montpellier, France

CHU de Nancy

Nancy, France

CHU de Nantes

Nantes, France

CHU de Nice

Nice, France

AP-HP - Hôpital Ténon

Paris, France

CHU de Poitiers

Poitiers, France

CHU de Rennes

Rennes, France

CHRU de Strasbourg

Strasbourg, France

CHU de Toulouse

Toulouse, France